Provided by Tiger Trade Technology Pte. Ltd.

EVEREST MED

30.140
+2.1607.72%
Volume:9.34M
Turnover:277.40M
Market Cap:10.67B
PE:-33.87
High:30.480
Open:28.020
Low:28.020
Close:27.980
52wk High:58.600
52wk Low:22.700
Shares:354.00M
HK Float Shares:354.00M
Volume Ratio:2.31
T/O Rate:2.64%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.890
ROE:-1.18%
ROA:-1.06%
PB:1.75
PE(LYR):-33.87
PS:3.79

Loading ...

Movement Alert|EVEREST MED Falls 5.02% in Regular Trading, Post-Approval Rally Fades as Xingbituo PSVT Milestone Fully Priced In

Market Focus
·
Sep 09

Hong Kong Stock Market Flash | EVEREST MED Surges Over 5% in Morning Trade as China Approves NDA for PSVT Indication

Stock News
·
Sep 08

Movement Alert|EVEREST MED Rises 5.05% in Regular Trading, First Cardiovascular Drug Star Bi Tuo Approved by NMPA

Market Focus
·
Sep 08

Everest Med Lifts Issued Share Count to 354.08 Million in August on Option Exercises

Bulletin Express
·
Sep 04

Milestone Pharmaceuticals Says NMPA Approval Triggers $2 Mln Milestone Payment to the Co

Reuters
·
Sep 03

Everest Medicines Gets China Nod for CARDAMYST Application

MT Newswires Live
·
Sep 03

EVEREST MED Wins NMPA Approval for CARDAMYST Nasal Spray, First Self-Administered Treatment for Adult PSVT in China

Bulletin Express
·
Sep 03

Everest Medicines Says China NMPA Approves Cardamyst Nasal Spray for PSVT Conversion in Adults

Reuters
·
Sep 03

Everest Medicines - Nmpa Approves Cardamyst (Etripamil) Nda for Psvt in Adults in China

THOMSON REUTERS
·
Sep 03

EVEREST MED's pioneering cardiovascular treatment receives green light in China, introducing the first and only on-demand rescue therapy for adults with PSVT

Stock News
·
Sep 03

Movement Alert|EVEREST MED Rises 6.56% in Regular Trading, Rebounding After Recent Profit-Taking as mRNA Biotech Sector Recovers

Market Focus
·
Sep 02

Movement Alert|EVEREST MED Falls 5.19% in Regular Trading, mRNA Concept Pullback and Biotech Sector Weakness Weigh on Shares

Market Focus
·
Aug 31

Movement Alert|EVEREST MED Falls 5.2% in Regular Trading, mRNA Concept Sentiment Cooling and Sector Weakness Trigger Pullback

Market Focus
·
Aug 28

Movement Alert|EVEREST MED Rises 5.16% in Regular Trading, mRNA Momentum and Strong Earnings Continue to Fuel Rally

Market Focus
·
Aug 26

Market Sentiment Stabilizes as Sanctions Prove Largely Symbolic; Tech Benchmarks Surge on Potential Dovish Fed Signals

Stock News
·
Aug 25

Everest Med Surges Over 17% in Afternoon Trade as Core Drug Nefecon Drives Strong Revenue Growth

Deep News
·
Aug 25

Midday Market Snapshot: Hang Seng Index Slips 0.25% in Morning Session, Mainland Property Stocks Rally Broadly

Stock News
·
Aug 25

Movement Alert|EVEREST MED Rises 5.14% in Regular Trading, mRNA Catalyst Sustains as Broker Reaffirms Buy Rating

Market Focus
·
Aug 25

mRNA Sector Marks Historic Clinical Win, Everest Medicines' Self-Developed Pipeline Gains Prominence

Deep News
·
Aug 24

Movement Alert|EVEREST MED Rises 5.28% in Regular Trading, Technical Rebound as mRNA Catalyst Lingers and Broker Maintains Buy Rating

Market Focus
·
Aug 24